Your browser doesn't support javascript.
loading
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.
Groeneveldt, Christianne; Kinderman, Priscilla; van Stigt Thans, Jordi J C; Labrie, Camilla; Griffioen, Lisa; Sluijter, Marjolein; van den Wollenberg, Diana J M; Hoeben, Rob C; den Haan, Joke M M; van der Burg, Sjoerd H; van Hall, Thorbald; van Montfoort, Nadine.
Afiliação
  • Groeneveldt C; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Kinderman P; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van Stigt Thans JJC; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Labrie C; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Griffioen L; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Sluijter M; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Wollenberg DJM; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hoeben RC; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • den Haan JMM; Molecular Cell Biology and Immunlogy, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • van der Burg SH; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van Hall T; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • van Montfoort N; Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands nvanmontfoort@lumc.nl.
J Immunother Cancer ; 10(7)2022 07.
Article em En | MEDLINE | ID: mdl-35853671
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido